Alaunos Therapeutics, Inc. (TCRT) Shareholders’ equity 2016–2025
Alaunos Therapeutics, Inc. (TCRT) shareholders’ equity at each fiscal year-end, per SEC filings.
$2.2MFY2025 · since FY2016: -$77.3M → $2.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $2.2M | +4.4% |
| FY2024 | $2.1M | -67.3% |
| FY2023 | $6.3M | -83.6% |
| FY2022 | $38.6M | -33.6% |
| FY2021 | $58.1M | -53.2% |
| FY2020 | $124.0M | — |
| FY2018 | $85.6M | +188.4% |
| FY2017 | -$96.8M | -25.2% |
| FY2016 | -$77.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice